KELNOR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Kelnor, and when can generic versions of Kelnor launch?
Kelnor is a drug marketed by Barr and is included in one NDA.
The generic ingredient in KELNOR is ethinyl estradiol; ethynodiol diacetate. There are twenty-six drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; ethynodiol diacetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for KELNOR?
- What are the global sales for KELNOR?
- What is Average Wholesale Price for KELNOR?
Summary for KELNOR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 6 |
| Patent Applications: | 48 |
| Drug Prices: | Drug price information for KELNOR |
| Drug Sales Revenues: | Drug sales revenues for KELNOR |
| DailyMed Link: | KELNOR at DailyMed |
US Patents and Regulatory Information for KELNOR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Barr | KELNOR | ethinyl estradiol; ethynodiol diacetate | TABLET;ORAL-28 | 076785-001 | May 23, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
